成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate

Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate Struktur
1383001-34-0
CAS-Nr.
1383001-34-0
Englisch Name:
Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate
Synonyma:
Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate;Cyclopropanecarboxylic acid, 1-[[[4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy]methyl]-, methyl ester
CBNumber:
CB42632308
Summenformel:
C18H26BNO5
Molgewicht:
347.21
MOL-Datei:
1383001-34-0.mol

Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate Eigenschaften

Siedepunkt:
447.0±45.0 °C(Predicted)
Dichte
1.15±0.1 g/cm3(Predicted)
pka
4.67±0.32(Predicted)

Sicherheit

Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Tetranov Biopharm 13526569071
 sales@leadmedpharm.com China 7906 64
  • Methyl 1-(((4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)Methyl)cyclopropanecarboxylate
  • Cyclopropanecarboxylic acid, 1-[[[4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy]methyl]-, methyl ester
  • 1383001-34-0
  • C18H26BNO5
Copyright 2019 ? ChemicalBook. All rights reserved